GLP-1 weight-loss telehealth, compared honestly

Dozens of services will sell you semaglutide or tirzepatide online. The question none of them answers straight is the one that matters most in 2026: are you getting the FDA-approved drug (Wegovy, Zepbound, Ozempic) or a compounded copythat the FDA has not reviewed — and, increasingly, is moving to shut down? We don’t sell any of these. Here is the honest map.

What changed in 2026 — read this first

Cheap “compounded semaglutide” was legal mainly because the branded drugs were in shortage. That is over: the FDA declared the tirzepatide shortage resolved October 2, 2024 and the semaglutide shortage resolved February 21, 2025, which ended the blanket permission to mass-produce copies. In 2026 the FDA has issued dozens of warning letters to telehealth companies over compounded-GLP-1 marketing and proposed closing the main outsourcing-facility supply channel, while Novo Nordisk and Eli Lilly sue compounders directly.

The upshot for you: the FDA-approved branded drugs are now the mainstream path, often at self-pay prices that didn’t exist a year ago — and a service still built entirely on compounded copies is the one most exposed to a supply cut. What is still legal is branded prescribing and narrow, patient-specific compounding where a prescriber documents a real clinical need.

By the pharmaranks editorial teamReviewed against the U.S. FDA (drug-shortage & compounding policy, warning letters) and each service's own current pages sourcesUpdated Aug 2, 2026How we research

Re-checked against each company’s own live pages on 2026-08-02: 5 of 7 services confirmed unchanged. Ro and Hims & Hers block automated requests, so their entries stand on the July reading — verify those two on their own sites.

Branded vs. compounded: the one distinction to get right

FDA-approved (branded)

Wegovy, Zepbound, Ozempic, Mounjaro and the new oral pill Foundayo (orforglipron). It is FDA-approved and made by Novo Nordisk or Eli Lilly under FDA-inspected manufacturing (cGMP), with each batch tested to FDA-approved specifications for identity, potency, purity and sterility. Costs more than a copy, but it is the exact drug studied in the trials — and insurance can cover it.

Compounded

A pharmacy mixes the same active molecule into its own product. Cheaper, but not FDA-approved and not reviewed for safety, potency or quality — so it depends entirely on the pharmacy. Legal now only for a documented, patient-specific need, and never covered by insurance. Same molecule is not the same as the same product.

Both carry the same FDA boxed warning for thyroid C-cell tumors and are contraindicated for a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2. For the drugs themselves — average trial weight loss, the safety facts and our recall-safety ratings — see our weight-loss medications comparison.

The services at a glance

Read the model badge on each — FDA-approved branded, both branded and compounded, or compounded-only. This is a comparison, not a ranking; the right one depends on your insurance, your history and your budget.

GLP-1 weight-loss telehealth services compared by medication model, consult type, insurance help and price
Service	Medications	Consult	Insurance	Read / go
Ro (Ro Body) FDA-approved only	FDA-approved (branded)	Online intake, an eligibility decision usually within two days, and lab work (through Quest, or an at-home kit) built into the program	A dedicated insurance concierge that runs a free coverage check up front and handles prior-authorization paperwork	Review
Sesame (Success by Sesame) FDA-approved only	FDA-approved (branded)	A video visit with a provider you choose yourself (a rarity here), unlimited messaging, and lab work through Quest in most states	Sesame does not bill insurance for the visit or subscription (that part is cash-pay)	Review Compare online visit prices
Hims & Hers FDA-approved (after a 2026 pivot)	FDA-approved (branded)	Asynchronous only	Now bills commercial insurance for the branded drugs (new since the branded pivot) and integrates the Novo Nordisk savings card	Review
Found Branded + compounded	Branded + compounded	A video visit with a clinician, many obesity-medicine trained, who can pivot across drug classes	A free insurance coverage check before you pay and provider-led prior-authorization for the branded drugs	Review
Noom Med Branded + compounded	Branded + compounded	An online intake reviewed by a licensed clinician, with the medication delivered if prescribed	Helps pursue coverage for the branded drugs	Review
LifeMD FDA-approved (branded)	FDA-approved (branded)	Video visits on a primary-care model, so the GLP-1 prescriber can also manage the rest of your health (labs, chronic conditions, other prescriptions), not just a weight-only questionnaire	Branded prescriptions routed through insurance via the primary-care visit	Review
Henry Meds Compounded only	Compounded only (not FDA-approved)	An online model built around fast, low-cost access to the compounded drug	None	Review

Prices and medication menus are self-pay and as of mid-2026 from each service’s own pages; these programs are changing fast, so confirm current details before you enroll.

Ro (Ro Body)

FDA-approved only

Medications: Branded, FDA-approved GLP-1s: Wegovy (pen and the new oral pill), Zepbound (including the KwikPen), Ozempic, and Foundayo (orforglipron). Ro's current weight-loss menu is branded FDA-approved drugs only — no compounded option is listed.
Consult & labs: Online intake, an eligibility decision usually within two days, and lab work (through Quest, or an at-home kit) built into the program; 1:1 coaching and unlimited provider messaging are included.
Insurance: A dedicated insurance concierge that runs a free coverage check up front and handles prior-authorization paperwork — the most hands-on insurance help of the services here.
Cost: A membership (about $39 the first month, then roughly $149/mo, or as low as ~$74/mo prepaid annually) with the medication billed separately at manufacturer self-pay prices; with covered insurance and a savings card the drug can fall to a low copay. As of mid-2026 — verify current.

Our read: The cleanest FDA-approved path with the strongest insurance support. If your plan might cover a GLP-1 at all, Ro's concierge is built to find and fight for it — which beats any cash-pay discount when it works.

Watch: The membership fee and the medication are two separate charges — the low membership number is not your total.

Visit Ro

Sources: Ro — Weight Loss (Ro Body) program ↗ · Ro — Weight-loss pricing ↗

Sesame (Success by Sesame)

FDA-approved only

Medications: Branded, FDA-approved drugs only — Sesame's weight-loss page lists Wegovy (pen and pill), Zepbound, Ozempic, Mounjaro and Rybelsus, with no compounded option shown.
Consult & labs: A video visit with a provider you choose yourself (a rarity here), unlimited messaging, and lab work through Quest in most states.
Insurance: Sesame does not bill insurance for the visit or subscription (that part is cash-pay); your own pharmacy insurance can still cover the branded drug, and the weight-loss program's providers can file the prior-authorization paperwork.
Cost: Care is roughly $59–$99/mo (cash-pay); the medication is billed separately at self-pay prices starting around $149/mo and rising with dose. With covered insurance plus a savings card the drug can drop to a low copay. As of mid-2026 — verify current.

Our read: The pick if you want to choose your own clinician and keep everything FDA-approved. You do the mental arithmetic (care fee plus a separately-billed drug), but you are never routed toward a compounded copy.

Watch: Two separate bills — the subscription and the medication — on possibly different cycles; budget the sum, not the sticker.

Compare online visit prices Sponsored link — we may earn a commission at no extra cost to you, and it did not affect what this page says. Details

Sources: Sesame — weight-loss medications (branded menu) ↗

Hims & Hers

Publicly tradedFDA-approved (after a 2026 pivot)

Medications: Now centered on branded, FDA-approved semaglutide — injectable Wegovy (including the higher-dose 7.2 mg), the oral Wegovy pill, and Ozempic. Hims received one of the FDA's 2025 warning letters over compounded-GLP-1 marketing, then settled with Novo Nordisk in March 2026 and moved new patients to branded products, saying it will no longer advertise compounded GLP-1s and will keep them only for the limited set of patients whose clinical needs a commercial product cannot meet.
Consult & labs: Asynchronous only — a provider reviews your intake and replies by message, usually within a day. No video visits, and no lab work is ordered or required.
Insurance: Now bills commercial insurance for the branded drugs (new since the branded pivot) and integrates the Novo Nordisk savings card; a covered patient can reach a very low copay.
Cost: A weight-loss membership (about $39 the first month, then roughly $149/mo) with the drug separate — oral Wegovy from about $149/mo and injectable Wegovy around $299/mo self-pay. As of mid-2026 — verify current.

Our read: A publicly-traded platform that has moved decisively to FDA-approved medicine and is one of the few offering the oral Wegovy pill cheaply. The trade-off is the thinnest clinical touch here: async-only, no labs — fine for a straightforward start, less so if your history is complicated.

Watch: Async-only means no clinician actually sees or examines you — you are responsible for flagging your full history in the intake.

Visit Hims & Hers

Sources: Hims — Weight Loss ↗ · Hims & Hers — Strategic shift to FDA-approved GLP-1s / Novo Nordisk collaboration (Mar 9, 2026) ↗ · FDA — Warning letter, Hims & Hers Health, Inc. dba Hers (Sep 9, 2025) ↗

Found

Branded + compounded

Medications: The widest menu here: branded GLP-1s routed through insurance (Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo and more), compounded semaglutide/tirzepatide as a cash-pay path, and non-GLP-1 options (metformin, bupropion-naltrexone, phentermine, topiramate) matched to the patient rather than defaulted.
Consult & labs: A video visit with a clinician, many obesity-medicine trained, who can pivot across drug classes; labs ordered when the history warrants rather than routinely.
Insurance: A free insurance coverage check before you pay and provider-led prior-authorization for the branded drugs.
Cost: Roughly $99–$289/mo depending on plan and commitment, medication included on the compounded track; Found does not publish full pricing until you complete intake. As of mid-2026 — verify current.

Our read: The strongest clinical model for a complicated case — real obesity-medicine expertise and the ability to change course if the first drug fails. Just steer deliberately toward its branded, insurance-covered track; the cash-pay default can be a compounded copy.

Watch: Two concrete things: pricing is not shown until after intake, and reviewers report a multi-month commitment with an early-cancellation fee — read the terms before you enroll.

Visit Found

Sources: Found — weight-care program ↗

Noom Med

Branded + compounded

Medications: Branded GLP-1s (Wegovy, Ozempic, Zepbound) alongside a compounded track — Noom's “GLP-1Rx Plus” is compounded tirzepatide, which Noom's own disclosure says is “produced in an FDA-registered facility but has not been reviewed by the FDA for safety, efficacy, or quality.” The whole program is wrapped in Noom's behavior-change coaching.
Consult & labs: An online intake reviewed by a licensed clinician, with the medication delivered if prescribed; the differentiator is the psychology-based coaching curriculum, not the clinical exam.
Insurance: Helps pursue coverage for the branded drugs; the compounded and all-inclusive tiers are cash-pay.
Cost: All-inclusive tiers that bundle care, coaching and medication — a compounded microdose tier from about $79 to start / ~$199/mo, and a branded-telehealth tier around $39 to start / ~$99/mo with the drug billed separately. As of mid-2026 — verify current.

Our read: Best if the coaching is the point — Noom's habit program is the most developed here and is included. On the medication itself, know which track you are on: its cheapest bundle is a compounded tirzepatide that, by Noom's own words, the FDA has not reviewed.

Watch: Read which tier you are buying — the all-inclusive price can be a compounded drug, not the branded one.

Visit Noom Med

Sources: Noom Med — program & medications ↗ · Noom Med — plans & pricing ↗

LifeMD

Publicly tradedFDA-approved (branded)

Medications: Branded, FDA-approved GLP-1s inside a full primary-care telehealth membership — its weight-management page lists Wegovy (pen and pill), Zepbound (pen and vial), Ozempic, Saxenda and Foundayo, all marked insurance-eligible; LifeMD has moved away from compounded GLP-1s toward direct manufacturer supply.
Consult & labs: Video visits on a primary-care model, so the GLP-1 prescriber can also manage the rest of your health (labs, chronic conditions, other prescriptions), not just a weight-only questionnaire.
Insurance: Branded prescriptions routed through insurance via the primary-care visit; LifeMD advertises copays as low as $0 for covered patients.
Cost: A membership plus the medication — a covered branded drug can reach a low copay, and self-pay branded prices run into the mid-hundreds per month depending on the drug. As of mid-2026 — verify current.

Our read: Makes the most sense if you want one telehealth doctor for weight and everything else, on FDA-approved medicine with insurance routing built in. The primary-care model means the prescriber sees your whole picture, not just a number on a scale.

Visit LifeMD

Sources: LifeMD — weight management (branded, FDA-approved menu) ↗

Henry Meds

Compounded only

Medications: Compounded semaglutide and compounded tirzepatide. By Henry's own legal disclosure, “most medications prescribed via Henry Meds are compounded medications,” and compounded drugs are not FDA-approved. There is no branded, FDA-approved GLP-1 on the platform as a fallback, and no insurance.
Consult & labs: An online model built around fast, low-cost access to the compounded drug.
Insurance: None — cash-pay only.
Cost: Among the lowest headline prices in the genre — commonly cited around $149/mo for compounded semaglutide and ~$349/mo for compounded tirzepatide, medication included. As of mid-2026 — verify current.

Our read: The cheapest entry point, and the one most exposed to the 2026 shift: a compounded-only platform is exactly the model the FDA's enforcement and the Novo/Lilly lawsuits are aimed at, and with no branded drug on the platform, a supply cut means starting over somewhere else. If you begin here, have a branded-access plan B — and know the drug you are getting is not FDA-reviewed.

Watch: No FDA-approved medication and no insurance on the platform — if the compounded supply is enjoined, there is nothing to switch to without changing providers.

Visit Henry Meds

Sources: Henry Meds — medication notifications (its own compounded-medication disclosure) ↗

Red flags before you pay

“Compounded semaglutide” marketed as the same as Wegovy or Ozempic. It contains the same active molecule, but a compounded drug is not FDA-approved and has not been reviewed for safety, potency or quality — the FDA has warned companies specifically for implying they are equivalent.
A price that looks too cheap for a branded drug. Real Wegovy or Zepbound has a manufacturer floor; a $150 “semaglutide” is almost always compounded, not the branded medicine.
An oral compounded “semaglutide” troche or drop. The only FDA-approved oral semaglutide is Rybelsus/oral Wegovy, absorbed very differently — do not assume a compounded tablet or drop matches the injectable trial results.
No licensed prescriber, no medical intake, or a site that will not name its pharmacy. Legitimate services use US-licensed prescribers and can tell you whether the pharmacy is a named 503A or 503B facility.
A checkout with a long commitment or an early-cancellation fee buried in the terms. Titrating a GLP-1 takes months, but you should be able to stop; read the cancellation policy before the first charge.
A GLP-1 prescribed with no discussion of the boxed warning. Both semaglutide and tirzepatide carry an FDA boxed warning for thyroid C-cell tumors and are contraindicated in anyone with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 — a real evaluation asks.

How to choose

Check insurance first. If any plan you have might cover a GLP-1, that is almost always the cheapest route to the branded drug. Services with an insurance concierge — Ro and Found — are built to find and fight for it.
Want to stay fully FDA-approved? Ro (Ro Body), Sesame (Success by Sesame), Hims & Hers, LifeMD keep to branded, FDA-approved drugs as their standard menu, so you are not routed to a compounded copy by default.
Complicated history (other conditions, past drug failures)? A video-visit, obesity-medicine model (Found) or a primary-care model (LifeMD) sees more than a weight-only questionnaire.
Cheapest possible and comfortable with the trade-off? Compounded-only services cost least but carry the 2026 supply and legal risk, no insurance, and a drug the FDA has not reviewed — go in with a branded plan B.

Frequently asked questions

Is compounded semaglutide still legal in 2026?

Only in narrow cases. The mass-compounding of copies was permitted mainly because the branded drugs were on the FDA's shortage list — and those shortages were declared resolved (tirzepatide in October 2024, semaglutide in February 2025), which ended the blanket permission. What remains legal is patient-specific 503A compounding where a prescriber documents a genuine clinical need the commercial product cannot meet. In 2026 the FDA has been actively enforcing against telehealth marketing of compounded GLP-1s and has proposed closing the main outsourcing-facility supply channel, so routine compounded access is narrowing, not expanding.

Which telehealth services use FDA-approved drugs rather than compounded copies?

Among the major services, Ro, Sesame and LifeMD keep to FDA-approved branded GLP-1s, and Hims & Hers moved to branded products for new patients after its 2026 settlement with Novo Nordisk (keeping compounded only for a limited set of documented clinical needs). Found and Noom Med offer both branded and compounded — so on those, ask specifically for the branded, FDA-approved drug. Henry Meds is compounded-only. Always confirm on the service's own current page, since these models are changing quickly.

Is compounded semaglutide dangerous?

It is not automatically dangerous — it usually contains the same active molecule as the branded drug — but it skips the FDA review that verifies a specific product's identity, potency, purity and sterility, so quality depends entirely on the compounding pharmacy. The FDA has reported dosing errors (people measuring their own doses from vials) and problems with some unapproved products. If you use a compounded GLP-1, a 503B outsourcing facility is FDA-inspected to a higher manufacturing standard than a 503A pharmacy, and you should be able to learn which one made your drug.

Why is branded Wegovy or Zepbound suddenly more affordable?

Because the manufacturers responded to the compounding boom by launching direct self-pay prices. Cash-pay branded Wegovy and Zepbound now run in the low-to-mid hundreds per month through several telehealth services and the makers' own direct channels — far below the $900–$1,400 full retail price, though still above a compounded copy. If you have insurance that covers a GLP-1, a savings card can bring the branded drug down to a low copay, which is usually the cheapest legitimate path of all.

Do I need insurance to get a GLP-1 through telehealth?

No — every major service offers a cash-pay path. But insurance, when it covers a GLP-1, is almost always the cheapest route to the branded drug, so it is worth checking first. Services like Ro and Found run a free coverage check and handle the prior-authorization paperwork; Sesame's and LifeMD's providers can file it too. Some Medicare Part D plans may also cover a GLP-1 depending on the diagnosis — check your own plan.

Is a GLP-1 prescribed online safe to take?

A GLP-1 obtained through a legitimate telehealth service — a US-licensed prescriber, a real medical intake, and an FDA-approved drug or a properly compounded one — is the same medicine your doctor would prescribe, and these drugs are well studied. The risks are the ordinary ones of the drug (nausea and GI effects are common; the label carries a boxed warning for thyroid C-cell tumors and contraindications for a personal or family history of medullary thyroid carcinoma or MEN 2, plus warnings for pancreatitis and gallbladder disease) plus the specific risk of a low-touch service missing something in your history. This is general information, not medical advice — the drug and dose are a decision for you and a prescriber.

Does PharmaRanks sell or recommend any of these services?

No. We are an independent ratings authority — we do not sell medications, we are not a telehealth service, and we take no commission from the companies on this page. This comparison is built from each service's own current pages and from FDA primary sources so you can judge them yourself. We favor FDA-approved medicine because it has been reviewed for safety and quality, not because any company paid for placement.

Primary sources

Service-specific facts are cited on each card, drawn from the company’s own current pages. Regulatory dates and enforcement come from the FDA sources above.

PharmaRanks is an independent ratings authority. We do not sell medications, are not a telehealth service, and take no commission from any company on this page. This is general reference information, not medical advice and not an endorsement of any service — prices, medication menus and policies change often, so verify current details on the service’s own site, and decide on any medication with a licensed prescriber.